Malignant neoplasms of the eye, orbit, and adnexa refer to the development of cancerous tumors in the structures of the eye, the surrounding orbit (eye socket), and its adnexa (related tissues and structures). These tumors can arise from various cell types within these areas and can lead to significant health concerns and potential vision loss.
Causes of malignant neoplasms of the eye, orbit, and adnexa:
Certain genetic mutations or inherited conditions can increase the risk of developing eye and orbital cancers.
Exposure to certain substances or radiation may contribute to the development of malignant neoplasms in the eye and its surrounding structures.
The risk of developing eye and orbital cancers tends to increase with age.
Some pre-existing eye conditions, such as retinoblastoma (a rare eye cancer in children), may increase the likelihood of developing other malignant neoplasms in the eye or orbit.
Individuals with weakened immune systems, such as those undergoing organ transplantation or with HIV/AIDS, may have an increased risk of developing eye and orbital cancers.
Signs and symptoms of malignant neoplasms of the eye, orbit, and adnexa:
The diagnosis of malignant neoplasms of the eye, orbit, and adnexa include:
Comprehensive eye examination
This includes visual acuity testing, assessment of eye structures, and evaluation of the optic nerve.
Imaging tests
Imaging techniques such as computed tomography (CT) scan, magnetic resonance imaging (MRI), or ultrasound may be used to visualize the eye, orbit, and surrounding tissues, and detect any tumor presence, size, and extent.
Biopsy
A tissue sample may be obtained from the suspected tumor for pathological analysis to determine if it is cancerous and the specific type of malignancy.
Evaluation of lymph nodes
Lymph nodes in the neck or other areas may be assessed to determine if the cancer has spread.
Consultation with a specialist
Referral to an ophthalmologist or an ocular oncologist may be necessary for further evaluation, management, and treatment planning.
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation
Note: Continue the 100 percent rating beyond the cessation of any surgical, X-ray, antineoplastic chemotherapy, or other therapeutic procedure. Six months after discontinuance of such treatment, the appropriate disability rating will be determined by mandatory VA examination. Any change in evaluation based upon that or any subsequent examination will be subject to the provisions of §3.105(e) of this chapter. If there has been no local recurrence or metastasis, evaluate based on residuals
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that do not require therapy comparable to that for systemic malignancies:
Separately evaluate visual and nonvisual impairment, e.g., disfigurement (diagnostic code 7800), and combine the evaluations
| Description | Percentage |
|---|---|
|
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation |
100 |
Need help with Medical Compensation? If your disability claim is not clearly supported by your medical records along with evidence, your claim can be denied. We have helped thousands of Veterans claim the compensation they deserve.
Get More InfoWe have Developed an Exclusive App for Veterans to benefit from our Knowledge Base that can help you not just with Medical Compensation but many other Features you can benefit from as a Veteran.
